Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Short Interest Up 127.8% in September
MarketBeat
Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totaling 1,280,000 shares, an increase of 127.8% from the August 31st total of 561,800 shares. Approximately 5.7% of the company's stock are sold short. Based on an average daily volume of 1,300,000 shares, the short-interest ratio is currently 1.0 days. Based on an average daily volume of 1,300,000 shares, the short-interest ratio is currently 1.0 days. Approximately 5.7% of the company's stock are sold short.
NASDAQ:ACRV
